CTOs on the Move

Med-Valu

www.medvalu.com

 
Med-Valu, Inc. is a Dublin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.medvalu.com
  • 485 Metro Pl S Ste 200
    Dublin, OH USA 43017
  • Phone: 614.684.2360

Executives

Name Title Contact Details

Similar Companies

Geary Community Hospital

Geary Community Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Junction City, KS. To find more information about Geary Community Hospital, please visit www.gchks.org

FTI Healthcare

FTI Healthcare is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tampa YMCA

The Y is a leading nonprofit committed to strengthening community through youth development, healthy living, and social responsibility.

Aldera

Aldera is the new name for Healthation. Healthation accelerated the business of healthcare. Aldera brings the focus and foresight to improve it. While our name has changed, our solutions remain resilient. Our service remains deeply rooted in customer commitment. The post-healthcare reform landscape is a frontier fraught with challenges. Our expert knowledge of the terrain and our flexible payer platform prepares healthcare payers and administrators to confidently navigate the shifts.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.